Endocrine treatment of prostate cancer - recent developments and the future. Part 1: maximal androgen blockade, early vs delayed endocrine treatment and side-effects

BJU Int. 1999 Jan;83(2):161-70. doi: 10.1046/j.1464-410x.1999.00955.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Androgen Antagonists / adverse effects
  • Androgen Antagonists / therapeutic use*
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Erectile Dysfunction / etiology
  • Forecasting
  • Humans
  • Libido
  • Male
  • Meta-Analysis as Topic
  • Orchiectomy* / adverse effects
  • Prostatic Neoplasms / therapy*
  • Randomized Controlled Trials as Topic

Substances

  • Androgen Antagonists
  • Antineoplastic Agents